Vanguard Group Inc Electro Core, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.21 - $5.63 $262 - $7,026	1,248 Added 0.06%	2,191,280 $569,000
Q1 2022 May 13, 2022	SELL	$0.5 - $0.88 $94,677 - $166,632	-189,355 Reduced 7.96%	2,190,032 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$0.58 - $1.09 $7,338 - $13,791	-12,653 Reduced 0.53%	2,379,387 $1.39 Million
Q3 2021 Nov 12, 2021	BUY	$0.93 - $1.18 $91,972 - $116,696	98,895 Added 4.31%	2,392,040 $2.7 Million
Q2 2021 Aug 13, 2021	BUY	$1.19 - $2.06 $2.73 Million - $4.72 Million	2,293,145 New	2,293,145 $2.73 Million

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $503M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.